CliffBio
small molecule

DIMETHYL FUMARATE

DIMETHYL FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameDIMETHYL FUMARATE
Active ingredientDIMETHYL FUMARATE
Strength240MG
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2020
Marketing statusDISCN

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DIMETHYL FUMARATE patent cliff — loss of exclusivity — | CliffBio